Literature DB >> 15154934

Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy.

M Taskiran1, V Rasmussen, B Rasmussen, T Fritz-Hansen, H B W Larsson, G B Jensen, J Hilsted.   

Abstract

AIMS: The pathophysiological mechanisms responsible for increased cardiovascular mortality in diabetic autonomic neuropathy (AN) are largely unknown. The aim was to determine the relative role of AN in the pathogenesis of cardiac diastolic dysfunction and left ventricular hypertrophy in Type 1 diabetes.
METHODS: Ten Type 1 diabetic patients with AN, defined by cardiovascular tests (AN+) and 10 age- and sex-matched patients without neuropathy (AN-) as well as 10 healthy subjects (C) participated in the study. Left ventricular diastolic function was assessed by Doppler echocardiography, whilst systolic function was evaluated by cine magnetic resonance (MR) imaging.
RESULTS: Doppler echocardiography showed a significant decrease in E/A ratio, i.e. the ratio between peak Early transmitral filling velocity during early diastole (E-wave) and peak transmitral Atrial filling velocity during late diastole (A-wave), in AN+ compared with C (P < 0.01) [0.95 +/- 0.08 (mean +/- sem) (AN+); 1.19 +/- 0.09 (AN-); 1.33 +/- 0.10 (C)]. The E-wave deceleration time was significantly shorter in AN+ compared with AN- and C (P < 0.02) [178 +/- 7 ms (AN+); 203 +/- 9 ms (AN-); 205 +/- 9 ms (C)]. Cine MR imaging showed a significantly greater left ventricular mass index in AN+ compared with C [103 +/- 4 g/m(2) (AN+) vs. 98 +/- 7 (AN-) and 92 +/- 4 g/m(2) (C), P < 0.05].
CONCLUSION: Autonomic neuropathy is associated with left ventricular hypertrophy and diastolic dysfunction in Type 1 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15154934     DOI: 10.1111/j.1464-5491.2004.01145.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  19 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

Review 2.  Cardiovascular autonomic neuropathy: diagnosis and management.

Authors:  Aaron I Vinik; Tomris Erbas
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 3.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

4.  Myocardial structure, function, and scar in patients with type 1 diabetes mellitus.

Authors:  Evrim B Turkbey; Jye-Yu C Backlund; Saul Genuth; Aditya Jain; Cuilian Miao; Patricia A Cleary; John M Lachin; David M Nathan; Rob J van der Geest; Elsayed Z Soliman; Chia-Ying Liu; João A C Lima; David A Bluemke
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

5.  Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial.

Authors:  R Pop-Busui; M J Stevens; D M Raffel; E A White; M Mehta; C D Plunkett; M B Brown; E L Feldman
Journal:  Diabetologia       Date:  2013-06-06       Impact factor: 10.122

Review 6.  Cardiovascular complications in patients with autonomic failure.

Authors:  Valeria Milazzo; Cristina Di Stefano; Alberto Milan; Agnese Ravera; Gabriele Sobrero; Luca Sabia; Franco Veglio; Simona Maule
Journal:  Clin Auton Res       Date:  2015-03-20       Impact factor: 4.435

7.  Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.

Authors:  Steven Orlov; David Z I Cherney; Rodica Pop-Busui; Leif E Lovblom; Linda H Ficociello; Adam M Smiles; James H Warram; Andrzej S Krolewski; Bruce A Perkins
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-19       Impact factor: 8.237

Review 8.  Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors:  Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

9.  Early signs of left ventricular dysfunction in adolescents with type 1 diabetes mellitus: the importance of impaired circadian modulation of blood pressure and heart rate.

Authors:  K Karavanaki; G Kazianis; I Konstantopoulos; E Tsouvalas; C Karayianni
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

10.  Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.